معرفی
Dr. Mark Kotter is a Physician Scientist at the Cambridge Stem Cell Institute, University of Cambridge. He specializes in spinal surgery and regenerative medicine, with a focus on degenerative cervical myelopathy and spinal cord injury. His work bridges clinical practice and translational research, supported by a NIHR Clinician Scientist Award.
- Education: MD (University of Graz), MPhil/PhD (University of Cambridge, lab of Prof. Robin Franklin).
- Clinical training: Medical University Vienna, University of Cambridge, and sub-specialist training with Prof. Michael Fehlings, University of Toronto.
Dr. Kotter’s research encompasses regenerative medicine for central nervous system disorders, including spinal cord injury, multiple sclerosis, and autism. His lab developed deterministic cellular reprogramming technology, enabling efficient production of human cell types for brain-on-chip models and advancing therapies. His team also conducts clinical trials like RECEDE Myelopathy, targeting regenerative treatments for cervical myelopathy.
His 15 most recent publications span neurodegenerative disease modeling, deterministic cellular reprogramming, biomechanical spinal cord compression markers, and clinical outcome assessments for cervical myelopathy. Key themes include synthetic biology, neurological rehabilitation, and translational research.
Scientific awards include the NIHR Clinician Scientist Award. He co-founded myelopathy.org, a charity dedicated to cervical myelopathy, and two spin-out companies: bit.bio (cellular reprogramming) and Meatable (cultured meat).
Dr. Kotter leads a basic science research lab and collaborates with MediciNova and myelopathy.org to translate findings into clinical applications. His work emphasizes interdisciplinary research, combining neuroscience, synthetic biology, and clinical neurosurgery.
